Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
about
Role of Radiotherapy in Modern Treatment of Hodgkin's LymphomaTailored strategies for radiation therapy in classical Hodgkin's lymphoma.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.PET/CT in the management of haematological malignancies.Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literatureBiologically conformal treatment: biomarkers and functional imaging in radiation oncology.Application of metabolic PET imaging in radiation oncology.The role of PET in Hodgkin's lymphoma and its impact on radiation oncology.PET imaging in lymphoma.FDG PET/CT in children and adolescents with lymphoma.Evolution of the techniques of radiation therapy in the management of lymphoma.When should FDG-PET be used in the modern management of lymphoma?Current role of FDG PET/CT in lymphoma.Modern radiotherapeutic strategies in the management of lymphoma.The concept and evolution of involved site radiation therapy for lymphoma.Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
P2860
Q34235785-450B8258-1A94-4F5E-81B1-E20E2824900CQ34610653-369C056F-E12A-4D49-8FBF-DBEA34DB362BQ36898355-F232E4F0-34CB-43CF-9366-6BA0ED66E300Q37088536-EAECB326-FBCC-4139-8095-F627562DAD85Q37178817-15A73638-74F8-418F-AB3C-588FA2653CCCQ37298667-4834E688-A809-478F-BB5A-04BBB118E6DAQ37580845-774A57DC-E537-4330-BCEB-8EE1D0C1AB04Q37788240-B2BF6200-7A6B-4F06-89E1-2FD5A1922330Q37810092-940DC3F3-441A-4CF7-AB50-F792F7C7FCE8Q38092706-F44B3236-0295-4517-9C3B-37ABB3E3D930Q38098056-280EC669-55B2-4EF3-B81F-951DB1ADB34DQ38153086-3C278A13-CD32-46B6-BE21-29FD16EB131CQ38187365-1994F110-0EBD-4DE8-B932-D66F5C58B464Q38373945-AF4CC402-221B-457A-BE22-098F5B8B1E7FQ38543470-53FA126C-D89A-43C0-B886-26C1575002BDQ38658450-DDB044AE-4C23-4EC5-892B-C7ABD8FDF5D8Q41497405-E382C1C1-2629-48A0-9DD5-326D0BEDC3E8Q47884628-5AC319AF-DE68-46D4-8C73-BEA217DE7055Q47990889-4D91919F-1F31-450E-A065-FB8D19D4BA4F
P2860
Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Is FDG-PET scan in patients wi ...... apy concept and dose painting?
@en
type
label
Is FDG-PET scan in patients wi ...... apy concept and dose painting?
@en
prefLabel
Is FDG-PET scan in patients wi ...... apy concept and dose painting?
@en
P2093
P1476
Is FDG-PET scan in patients wi ...... apy concept and dose painting?
@en
P2093
Aziz Bayla
Guillaume Bonniaud
Ivaldo Ferreira
Jean Lumbroso
Mithra Ghalibafian
Nicolas Magne
Theodore Girinsky
P304
P356
10.1016/J.RADONC.2007.07.003
P577
2007-08-23T00:00:00Z